Ifrah Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Sell |
3,501
-44
| -1% | -$19.6K | 0.43% | 48 |
|
|
2025
Q1 | $1.72M | Sell |
3,545
-273
| -7% | -$132K | 0.49% | 45 |
|
|
2024
Q4 | $1.54M | Sell |
3,818
-132
| -3% | -$53.2K | 0.42% | 48 |
|
|
2024
Q3 | $1.84M | Sell |
3,950
-102
| -3% | -$47.4K | 0.5% | 46 |
|
|
2024
Q2 | $1.9M | Sell |
4,052
-403
| -9% | -$189K | 0.54% | 44 |
|
|
2024
Q1 | $1.86M | Sell |
4,455
-102
| -2% | -$42.6K | 0.52% | 44 |
|
|
2023
Q4 | $1.85M | Sell |
4,557
-179
| -4% | -$72.8K | 0.54% | 41 |
|
|
2023
Q3 | $1.65M | Sell |
4,736
-49
| -1% | -$17K | 0.51% | 46 |
|
|
2023
Q2 | $1.68M | Sell |
4,785
-76
| -2% | -$26.7K | 0.51% | 45 |
|
|
2023
Q1 | $1.53M | Sell |
4,861
-119
| -2% | -$37.5K | 0.49% | 48 |
|
|
2022
Q4 | $1.44M | Sell |
4,980
-165
| -3% | -$47.6K | 0.47% | 48 |
|
|
2022
Q3 | $1.49M | Sell |
5,145
-38
| -0.7% | -$11K | 0.51% | 49 |
|
|
2022
Q2 | $1.46M | Sell |
5,183
-82
| -2% | -$23.1K | 0.47% | 50 |
|
|
2022
Q1 | $1.37M | Buy |
5,265
+2,651
| +101% | +$692K | 0.39% | 52 |
|
|
2021
Q4 | $574K | Buy |
+2,614
| New | +$574K | 0.15% | 113 |
|